Nucleobase adducts bind MR1 and stimulate MR1-restricted T cells.

Autor: Vacchini A; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Chancellor A; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Yang Q; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Colombo R; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Spagnuolo J; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Berloffa G; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Joss D; Department of Chemistry, University of Basel, Basel 4056, Switzerland., Øyås O; Department of Biosystems Science and Engineering and SIB Swiss Institute of Bioinformatics, ETH Zurich, Basel 4058, Switzerland., Lecchi C; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA., De Simone G; Department of Environmental Health Science, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano 20156, Italy., Beshirova A; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Nosi V; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Loureiro JP; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Morabito A; Department of Environmental Health Science, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano 20156, Italy., De Gregorio C; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Pfeffer M; Department of Chemistry, University of Basel, Basel 4056, Switzerland., Schaefer V; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Prota G; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Zippelius A; Cancer Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Stelling J; Department of Biosystems Science and Engineering and SIB Swiss Institute of Bioinformatics, ETH Zurich, Basel 4058, Switzerland., Häussinger D; Department of Chemistry, University of Basel, Basel 4056, Switzerland., Brunelli L; Department of Environmental Health Science, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano 20156, Italy., Villalta P; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.; Department of Medicinal Chemistry, University of Minnesota, Minneapolis, MN 55455, USA., Lepore M; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., Davoli E; Department of Environmental Health Science, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano 20156, Italy., Balbo S; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA., Mori L; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland., De Libero G; Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland.

Publikováno v: Science immunology [Sci Immunol] 2024 May 10; Vol. 9 (95), pp. eadn0126. Date of Electronic Publication: 2024 May 10.

Potent neutralization by monoclonal human IgM against SARS-CoV-2 is impaired by class switch.

Autor: Callegari I; Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland.; MS Center, Neurologic Clinic and Policlinic, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland., Schneider M; Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland., Berloffa G; Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland., Mühlethaler T; Biophysics Facility, Biozentrum, University of Basel, Basel, Switzerland., Holdermann S; Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland.; MS Center, Neurologic Clinic and Policlinic, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland., Galli E; Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland.; MS Center, Neurologic Clinic and Policlinic, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland., Roloff T; Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.; Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland., Boss R; Federal Food Safety and Veterinary Office, Bern, Switzerland., Infanti L; Regional Blood Transfusion Service, Swiss Red Cross, Basel, Switzerland., Khanna N; Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland., Egli A; Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.; Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland., Buser A; Regional Blood Transfusion Service, Swiss Red Cross, Basel, Switzerland., Zimmer G; Institute of Virology and Immunology, Bern & Mittelhäusern, Switzerland.; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland., Derfuss T; Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland.; MS Center, Neurologic Clinic and Policlinic, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland., Sanderson NSR; Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland.; MS Center, Neurologic Clinic and Policlinic, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.

Publikováno v: EMBO reports [EMBO Rep] 2022 Jul 05; Vol. 23 (7), pp. e53956. Date of Electronic Publication: 2022 May 12.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection.

Autor: Schoefbaenker, Michael¹ (AUTHOR), Günther, Theresa¹ (AUTHOR), Lorentzen, Eva Ulla¹ (AUTHOR), Romberg, Marie-Luise¹ (AUTHOR), Hennies, Marc Tim¹ (AUTHOR), Neddermeyer, Rieke¹ (AUTHOR), Müller, Marlin Maybrit¹ (AUTHOR), Mellmann, Alexander² (AUTHOR), Bojarzyn, Chiara Robin¹ (AUTHOR), Lenz, Georg³ (AUTHOR), Stelljes, Matthias³ (AUTHOR), Hrincius, Eike Roman¹ (AUTHOR), Vollenberg, Richard⁴ (AUTHOR), Ludwig, Stephan¹ (AUTHOR), Tepasse, Phil-Robin⁴ (AUTHOR), Kühn, Joachim Ewald¹ (AUTHOR) kuehnj@uni-muenster.de

Publikováno v: PLoS Pathogens. 10/15/2024, Vol. 20 Issue 10, p1-27. 27p.

Health, Income and Inequality: Evidence from a Survey of Older Italians

Autor: Berloffa, G., Brugiavini, Agar, Rizzi, Dino

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3655::703d64afbc5d26e6a92ca59d1175f72d
http://hdl.handle.net/10278/12160